Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis

ClinicalTrials.gov ID: NCT06846541

Public ClinicalTrials.gov record NCT06846541. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 3:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Extension Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Long-term Safety, Efficacy, and Durability of Response to ESK-001

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of the ESK-001-018 long term extension is to evaluate the safety and efficacy of ESK-001 over time. The scientific questions it aims to answer are: * How safe is taking ESK-001 long-term in people with moderate to severe plaque psoriasis? * Does taking ESK-001 long-term reduce the severity of people's plaque psoriasis? Patients will enter the long-term extension study following completion of one of the parent studies (ESK-001-016 or ESK-001-017) and will receive open-label ESK-001 twice daily for 24 weeks. After 24 weeks, the first 200 patients meeting at least PASI-75 clinical response will be randomly assigned to receive ESK-001 or placebo. At any point during this time, the patients losing the initial clinical response may return to the open-label ESK-001 treatment. Patients who complete Week 48 will return to open-label ESK-001 treatment and they will receive ESK-001 until the end of the study or discontinuation. All the remaining patients not meeting the entry criteria for the randomized withdrawal phase will continue to receive open-label ESK-001 for the remainder of the study. Patients taking part in the study must be men or women aged at least 18 years old and have completed a previous (parent) study of ESK-001 in moderate to severe plaque psoriasis. Patients must consent and agree to: * ensure drug daily compliance until end of study or discontinuation. * visit the clinic for checkups and assessments. * provide blood and urine samples.

Study identification

NCT ID
NCT06846541
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Alumis Inc
Industry
Enrollment
1,680 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 8, 2025 (Actual)
Primary completion
Nov 2028 (Estimated)
Completion
Nov 2028 (Estimated)
Last update posted
Apr 13, 2026

2025 – 2028

United States locations

U.S. sites
92
U.S. states
25
U.S. cities
82
Facility City State ZIP Site status
Total Dermatology Birmingham Alabama 35203 —
Chandler Clinical Trials Chandler Arizona 85224 —
Alliance Dermatology Pheonix Arizona 85032 —
Scottsdale Clinical Trials Scottsdale Arizona 85260 —
Noble Clinical Research Tucson Arizona 85704 —
Northwest AR Clinical Trials Center PLLC Rogers Arkansas 72758 —
Zenith Research Inc. Beverly Hills California 90212 —
Exalt Clinical Research Inc Chula Vista California 91910 —
California Dermatology and Clinical Research Institute Encinitas California 92024 —
Raoof MD Encino California 91436 —
First OC Dermatology Research Inc Fountain Valley California 92708 —
Marvel Clinical Research LLC Huntington Beach California 92647 —
Long Beach Research Institute Long Beach California 90805 —
Olive View UCLA Education and Research Institute Los Angeles California 90024 —
Dermatology Research Associates Los Angeles California 90045 —
Wallace Medical Group Inc Los Angeles California 90056 —
Northridge Clinical Trials Northridge California 91325 —
Pasadena Clinical Trials Pasadena California 91101 —
Empire Clinical Research Pomona Pomona California 91767 —
Integrative Skin Science and Research Sacramento California 95815 —
Therapeutics Clinical Research San Diego California 92123 —
Southern California Clinical Research Santa Ana California 92701 —
Clinical Science Institute Dermatology Institute Santa Monica California 90404 —
Unison Clinical Trials Sherman Oaks California 91403 —
California Dermatology Institute Thousand Oaks Thousand Oaks California 91320 —
Sunwise Clinical Research LLC Walnut Creek California 94596 —
Clearlyderm Dermatology West Boca Raton Boca Raton Florida 33428 —
Driven Clinical Research Coral Gables Florida 33134 —
FXM Clinical Research Ft. Lauderdale LLC Fort Lauderdale Florida 33308 —
Direct Helpers Research Center Hialeah Florida 33012 —
Jacksonville Center for Clinical Research Jacksonville Florida 32216 —
Glick Skin Institute Margate Florida 33063 —
AppleMed Research Group Miami Florida 33126 —
FAX Pharma Clinical Research Inc Miami Florida 33146 —
FXM Clinical Research Miami LLC Miami Florida 33175 —
Las Mercedes Medical Research Miami Florida 33196 —
Procare Research Center Miami Gardens Florida 33014 —
San Marcus Research Clinic Inc - Miami Miami Lakes Florida 33014 —
Savin Medical Group LLC Miami Lakes Florida 33014 —
FXM Clinical Research Miramar LLC Miramar Florida 33027 —
Oceanic Research Group North Miami Beach Florida 33169 —
Renstar Medical Research Ocala Florida 34470 —
Lenus Research and Medical Group LLC Sweetwater Florida 33172 —
Advanced Clinical Research Institute Tampa Florida 33607 —
ForCare Medical Center Tampa Florida 33613 —
Arlington Dermatology Rolling Meadows Illinois 60008 —
NorthShore Medical Group Dermatology Skokie Skokie Illinois 60077 —
Dundee Dermatology West Dundee Illinois 60118 —
DS Research of Southern Indiana Clarksville Indiana 47129 —
Dawes Fretzin Clinical Research Group Columbus Indiana 47201 —
The Indiana Clinical Trials Center Plainfield Indiana 46168 —
The South Bend Clinic South Bend Indiana 46617 —
Equity Medical Bowling Green Kentucky 42104 —
DS Research of Kentucky Louisville Kentucky 40241 —
Velocity Clinical Research Baton Rouge Louisiana 70808 —
Tulane University School of Medicine New Orleans Louisiana 70112 —
MetroBoston Clinical Partners Brighton Massachusetts 02135 —
Michigan Center for Research Company Clarkston Michigan 48346 —
Henry Ford Medical Center Farmington Detroit Michigan 48202 —
Revival Research Institute Troy Michigan 48084 —
Grekin Skin Institute Warren Michigan 48088 —
Associated Skin Care Specialists Minnesota Clinical Study Center New Brighton Minnesota 55112 —
Cleaver Dermatology Kirksville Missouri 63501 —
Schlessinger MD Omaha Nebraska 68144 —
Las Vegas Clinical Trials Las Vegas Nevada 89030 —
NYC Health and Hospitals Elmhurst Elmhurst New York 11373 —
Pioneer Clinical Research NY New York New York 10016 —
Cameron Dermatology New York New York 10023 —
OptiSkin New York New York 10128 —
DermResearchCenter of New York Stony Brook New York 11790 —
Asheville Clinical Trials Asheville North Carolina 28803 —
WDC Cosmetic and Research Wilmington North Carolina 28405 —
Optima Research Boardman Boardman Ohio 44512 —
The Ohio State University Wexner Medical Center OSUWMC OSU Dermatology East Columbus Gahanna Ohio 43230 —
Dermatologists of Southwestern Ohio LLC Mason Ohio 45040 —
Unity Clinical Research UCR Oklahoma City Oklahoma 73118 —
Velocity Clinical Research Medford Oregon 97504 —
Oregon Medical Research Center Portland Oregon 97201 —
Paddington Testing Company Inc Philadelphia Pennsylvania 19103 —
UPMC Department of Dermatology Pittsburgh Pennsylvania 15213 —
Clinical Partners LLC Johnston Rhode Island 02919 —
Studies in Dermatology LLC Cypress Texas 77433 —
Modern Research Associates PLLC Dallas Texas 75231 —
Reveal Research Institute Frisco Texas 75033 —
Center for Clinical Studies Texas Medical Center Houston Texas 77004 —
Austin Institute for Clinical Research Houston Texas 77056 —
SMS Clinical Research Mesquite Texas 75149 —
Progressive Clinical Research San Antonio San Antonio Texas 78213 —
Center for Clinical Studies (CCS) - Webster/Clear Lake Location Webster Texas 77598 —
University of Utah Health Care Midvalley Health Center Murray Utah 84107 —
Jordan Valley Dermatology South Jordan Utah 84095 —
Frontier Dermatology Mill Creek Washington 98012 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 176 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06846541, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 13, 2026 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06846541 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →